Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright 2019© Refinitiv. Data may be intentionally delayed pursuant to supplier requirements. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Source: FactSetĭata are provided 'as is' for informational purposes only and are not intended for trading purposes. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Sources: FactSet, Tullett PrebonĬommodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Sources: FactSet, Tullett PrebonĬurrencies: Currency quotes are updated in real-time. Sources: FactSet, Dow Jonesīonds: Bond quotes are updated in real-time. Sources: FactSet, Dow JonesĮTF Movers: Includes ETFs & ETNs with volume of at least 50,000. Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Overview page represent trading in all U.S. Indexes: Index quotes may be real-time or delayed as per exchange requirements refer to time stamps for information on any delays. Copyright 2019© FactSet Research Systems Inc. Fundamental company data and analyst estimates provided by FactSet. International stock quotes are delayed as per exchange requirements. stock quotes reflect trades reported through Nasdaq only comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. Dividend Yield A company's dividend expressed as a percentage of its current stock price. Restricted stock typically is that issued to company insiders with limits on when it may be traded. To calculate, start with total shares outstanding and subtract the number of restricted shares. Public Float The number of shares in the hands of public investors and available to trade. Shares Outstanding Number of shares that are currently held by investors, including restricted shares owned by the company's officers and insiders as well as those held by the public. For companies with multiple common share classes, market capitalization includes both classes. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. Market Capitalization Reflects the total market value of a company. Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Hologic, Bayer Collaborate Globally for Breast Cancer Detection With Enhanced Mammography Solutionīayer Acquires Strawberry Assets of Britain's NIABīayer Aktiengesellschaft Announces the Maximum Acceptance Amount and the 2079 Notes Series Maximum Acceptance Amount for Its Invitation to Eligible Holders of its Outstanding EUR 1,500,000,000 Subordinated Resettable Fixed Rate Notes Due 2074īayer Aktiengesellschaft signed an agreement to acquire strawberry pipeline and commercial portfolio from NIAB.P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period. Traffic light parties: strengthen chemical siteĮvonik aims to create scope for investment with Group restructuringĪssociations warn of consequences of blanket ban on PFAS chemicalsīig Pharma bets on AI to speed up clinical trialsĪnother ten years of glyphosate? - Criticism of EU Commission Pharma lobby says EU ban on 'forever chemicals' would halt drug productionīayer to Present Latest Real-World Evidence of Menopausal Symptoms and Their Treatmentīayer AG Announces the Results of its Tender Offer in Respect of its EUR 1,500,000,000 Subordinated Resettable Fixed Rate Notes Due 2074 and EUR 1,000,000,000 Subordinated Resettable Fixed Rate Notes Due 2079 Ligand Pharmaceuticals Completes Acquisition of Novan AssetsĮnvironmentalists accuse glyphosate manufacturers of risk concealment Lemke on PFAS chemicals: Restrict hazardous substancesīusiness and union disappointed about 'chemical summit' Agreement at conference: global rules for toxic substances
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |